PlainRecalls
FDA Drug Moderate Class II Terminated

Losartan Pot/HCTZ 100/12.5 mg 90 Tabs NDC 72189-290-90 Packaged and Distributed By: Direct Rx Dawsonville, GA 30534 Mfg. For Macleods Pharma USA, Inc. Plainsboro, NJ 08540

Reported: June 1, 2022 Initiated: May 11, 2022 #D-0893-2022

Product Description

Losartan Pot/HCTZ 100/12.5 mg 90 Tabs NDC 72189-290-90 Packaged and Distributed By: Direct Rx Dawsonville, GA 30534 Mfg. For Macleods Pharma USA, Inc. Plainsboro, NJ 08540

Reason for Recall

CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits .

Details

Recalling Firm
Direct Rx
Units Affected
11 bottles
Distribution
FL
Location
Dawsonville, GA

Frequently Asked Questions

What product was recalled?
Losartan Pot/HCTZ 100/12.5 mg 90 Tabs NDC 72189-290-90 Packaged and Distributed By: Direct Rx Dawsonville, GA 30534 Mfg. For Macleods Pharma USA, Inc. Plainsboro, NJ 08540. Recalled by Direct Rx. Units affected: 11 bottles.
Why was this product recalled?
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits .
Which agency issued this recall?
This recall was issued by the FDA Drug on June 1, 2022. Severity: Moderate. Recall number: D-0893-2022.